EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, RPRX:

12 Aug 25 10:31
LAST:

36.33

CHANGE:
 0.14		OPEN:
36.20		HIGH:
36.53		ASK:
0.75		VOLUME:
487K
CHG(%):
0.39		PREV:
36.19		LOW:
36.11		BID:
0.41		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
12 Aug 2536.2036.5336.1136.33487K
11 Aug 2537.6637.9236.0636.193.53M
08 Aug 2537.1437.9736.9337.582.81M
07 Aug 2537.1337.2636.2737.014.33M
06 Aug 2536.9437.7736.6937.124.17M
05 Aug 2537.8138.0037.5737.913.28M
04 Aug 2537.2237.9137.2237.882.94M
01 Aug 2536.6637.2236.3737.111.88M
31 Jul 2537.0937.5536.7136.802.16M
30 Jul 2537.1037.5036.8437.122.84M

COMPANY PROFILE

Name:
About:Repros Therapeutics Inc. (?the Company?, ?RPRX,? or ?we,? ?us? or ?our?),  was organized on August 28, 1987. We are a development stage biopharmaceutical  company focused on the development of oral small molecule drugs for major unmet  medical needs. We have a proven track-record of efficient and rapid advancement  of our therapeutic candidates through clinical development.  Our current product pipeline includes:  Proellex  ? Phase 3 for the treatment of anemia associated with uterine fibroids  ? Phase 3 for the chronic treatment of uterine fibroids   ? Phase 2 for the treatment of endometriosis   Androxal  ? Planned Phase 2b trial to treat men with AIHH, with concomitant plasma   glucose and lipid elevations   ? Planned Phase 2b trial in men with low testosterone levels wanting to   improve or maintain their fertility a  ...
Sector:Health Care
Industry:Biotechnology: Biological Products (No Diagnostic Substances)
CIK:0897075

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

P/E Ratio:14.79
PEG Ratio:-0.02
EPS Ratio:2.45
PtB:2.31
Shares:421.37M
Market Cap:15.308B
52wk range:24.05 - 38.00

TECHNICALS

MA5:36.83
MA20:36.65
MA50:35.75
MA200:31.57
STO9:22.40
RSI14:51.92
WPR14:-97.67
MTM14:-0.36
ROC14:-0.01
Week High:37.97
Week Low:36.06
Month High:38.00
Month Low:35.24